Clinical Trials Directory

Trials / Completed

CompletedNCT03195959

Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension

Effect of Normobaric Hypoxia and Hyperoxia on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulmonary Hypertension (PH) is a severe disease with a bad prognosis. However, thanks to extensive research in this field, there are more and better treatment options that allow patients to participate in recreational activities at moderate altitude or bring up the question of air-travel. Still very few is known about the effects hypoxic conditions have on PH patients. The aim of this study is to investigate the effects of hypoxia in comparison to normoxia and hyperoxia on pulmonary hemodynamics in patients with pulmonary hypertension during routine right heart catheterisation. We aim to get insight into the pathophysiology of pulmonary hemodynamics under hypoxic conditions in comparison to normoxia and hyperoxia in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension compared with control patients, that are scheduled for right heart catheterisation due to dyspnea but have no PH.

Conditions

Interventions

TypeNameDescription
OTHERHypoxia and Hyperoxia10 minutes of breathing a gas mixture with FiO2 0.16 via a tight fitting mask. After 10 minutes of breathing ambient air (normoxia), patients were exposed to hyperoxia (FiO2 1.0) for 10 minutes.

Timeline

Start date
2017-06-22
Primary completion
2022-05-01
Completion
2022-05-01
First posted
2017-06-22
Last updated
2022-11-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03195959. Inclusion in this directory is not an endorsement.